ABSTRACT. The net balance of neutrophil elastase and its inhibitor, a,-antitrypsin (al-AT), is a critical determinant of connective tissue turnover during homeostasis and in disease states. In addition to liver-derived a,-AT, which translocates from blood to tissues, this elastase-a,-AT balance is maintained by expression of al-AT at the local tissue level in resident mononuclear phagocytes. Our previous studies have shown that this elastase-al-AT balance is also tightly controlled at a cellular level in that addition of exogenous neutrophil elastase (serpine-type elastase) to cultured mononuclear phagocytes is associated with an increase in expression of the al-AT gene. Subsequent studies have demonstrated that this novel regulatory loop involves interaction between exogenous neutrophil elastase and endogenous a,-AT inducing a structural rearrangement in the al-AT molecule and exposing highly conserved conformation-specific domain of a,-AT, which can then be recognized by a specific cell surface receptor, the serpinenzyme complex receptor. In the following study, we examined the effect of a bacterial metalloelastase, Pseudomonas aeruginosa elastase, on expression of a,-AT in human mononuclear phagocytes. We show that pseudomonas elastase inactivates monocyte-derived a,-AT by limited proteolysis but, in so doing, a,-AT becomes recognized by the serpin-enzyme complex receptor and mediates an increase in de novo synthesis of a,-AT in these cells. However, the concentrations of pseudomonas elastase needed to proteolytically inactivate al-AT in monocyte culture fluid are higher than those required for inactivation of purified plasma a,-AT. Results of experiments in this report show that this can be explained, at least in part, by binding of pseudomonas elastase to another endogenous protease inhibitor, a2-macroglobulin. Thus, the results of this study further define the elaborate mechanisms by which the host mononuclear phagocyte controls the elastase-a,-AT balance and, in turn, connective tissue turnover. (Pediatr Res 29: 133-140,1991) Abbreviations a,-AT, a,-antitrypsin LPS, lipopolysaccharide SEC, serpin-enzyme complex
At sites of inflammation or tissue injury, an array of proteolytic enzymes is released by neutrophils, platelets, damaged tissue, activation products of the complement, coagulation, and fibrinolytic pathways as well as by invading microorganisms. These enzymes must ultimately be inactivated to prevent incidental destruction of surrounding tissue and to allow for tissue repair. Proteinase inhibitors are produced by resident mononuclear phagocytes, as well as by liver, indicating that the host has local as well as remote potential mechanisms for proteinase inactivation at sites of inflammation. One proteinase inhibitor, al-AT, is particularly important in this regard because it inhibits a highly destructive enzyme, neutrophil elastase. Unregulated neutrophil elastase activity is probably responsible for destructive lung disease in al-AT-deficient and -sufiicient hosts and contributes to lung injury in cystic fibrosis and adult respiratory distress syndrome (1).
aI-AT is the archetype of the serine proteinase inhibitor (serpin) supergene family. It binds its target enzyme at a substratelike region within the carboxy terminal portion of the molecule. The enzyme is inactivated as a covalently stabilized enzymeinhibitor complex is formed. During complex formation, there is also structural rearrangement of the inhibitor and hydrolysis of its methionine-serine reactive-site peptide bond (2) .
The net functional activity of al-AT in complex biologic fluids may be modified by several factors. First, the reactive site methionine may be oxidized and, therein, al-AT rendered inactive as an elastase inhibitor (3) (4) (5) (6) (7) (8) . Second, al-AT may be inactivated by the limited proteolytic activity of endogenous and exogenous metallo-and thiol-enzymes (9) (10) (11) (12) (13) (14) . Several metallo-and thiolenzymes have been shown to cleave a,-AT at or near its reactivesite peptide bond, inactivating aI-AT without forming an enzyme-inhibitor complex. Third, the activity of aI-AT may be affected by the activity of other inhibitors present in fluids, including other serpins and inhibitors of the a2-macroglobulin class (15) . a2-Macroglobulin binds proteinases of the serine, carboxyl, thiol, and metalloproteinase classes. Proteinase inactivation results from rapid receptor-mediated clearance and intracellular degradation of the a2-macroglobulin-proteinase complexes. Fourth, the concentration of a,-AT in tissue is affected by extracellular factors that regulate the synthesis of orl-AT. We now know that synthesis of a,-AT in hepatocytes is regulated by the acute phase mediator IL-6 (16) . Synthesis of al-AT in mononuclear phagocytes is regulated by IL-6 (16), bacterial LPS (17) , and a novel feedback mechanism involving the neutrophil elastase-al-AT complex as mediator (18) (19) (20) . In the last case, a domain in the carboxy-terminal fragment of al-AT is newly exposed during the formation of the elastase-al-AT complex. This domain is recognized by a cell surface receptor, SEC receptor, and a SEC receptor-linked signal transduction system for up-regulation of a,-AT gene expression (20) . In the present study, we examined the effect of a prototype metalloelastase, P. aeru-ginosa elastase, on a,-AT gene expression and functional activity in a model cell culture system, primary culture of human peripheral blood monocytes. Pseudomonas elastase is capable of degrading connective tissue matrix proteins including elastin (2 I), collagen (22) , laminin (23) , serum proteins including IgG (24), C3 (25) , and al-AT (13, 26) as well as the lymphokines interferon-gamma (27) and IL-2 (28) . It has been shown to cleave a l -AT at the P r~~~' -M e t~~* bond adjacent to the reactive-site peptide bond, but the newly generated carboxy terminal fragment of a,-AT remains associated with the rest of the molecule by hydrophobic forces (26) . Thus, it is possible that this prototypic metalloenzyme inactivates aI-AT but, in so doing, exposes a receptor-binding domain and engages SEC receptor-mediated upregulation of al-AT gene expression. In this study, we examined the effect of pseudomonas elastase on monocyte-derived a]-AT by SDS-PAGE, the effect of pseudomonas elastase on synthesis of a,-AT in monocytes, and the possibility that there is uptake of pseudomonas elastase by monocytes. Rabbit anti-human al-AT and rabbit antihuman a2-macroglobulin were from Dako Corp., Santa Barbara, CA. LPS preparations extracted from Escherichia coli serotype 0 1 1 1:B4 by Westphal phenolic extraction were purchased from Sigma Chemical Co., St. Louis, MO. E. coli 01 13 LPS from Associates of Cape Cod, Inc., Woods Hole, MA, was also used. P. aeruginosa elastase was kindly supplied by Dr. Barbara Iglewski (Rochester, New York) and also purchased from Nagase and Company, Ltd., Tokyo, Japan. These preparations were homogeneous as demonstrated by SDS-PAGE and functionally active as demonstrated by digestion of Hide powder azure according to previously published methods (29) . There was <1 pg/ mL of LPS in these preparations as demonstrated by limulus amebocyte lysate assay (Associates of Cape Cod., Inc.). For each experiment, pseudomonas elastase was resuspended in the desired concentration in 18 mM Tris, pH 8.0, 10 mM CaC12, 30 mM NaCl buffer. Purified human plasma a2-macroglobulin was kindly supplied by Dr. L. Sottrup-Jensen (Aarhus, Denmark). Preparation of purified human plasma al-AT and purified porcine pancreatic elastase have been previously described (1 8).
Cell culture. Confluent monolayers of human peripheral blood monocytes from healthy individuals were established by adherence of dextran-purified leukocytes on charged tissue culture plastic (Primaria; Becton-Dickinson Labware, Lincoln Park, NJ) (1 7). Each individual had a normal a]-AT allotype as defined by isoelectric focusing and plasma concentrations of al-AT.
Metabolic labeling. Confluent monolayers were rinsed and incubated at 37°C in the presence of methionine-free medium containing [35S]methionine, 250 pCi/mL (pulse period). To determine the net synthesis of al-AT or control secretory proteins, cells were subjected to a short pulse interval (20 min) and radiolabeled proteins were detected in the cell lysate alone. To obtain radiolabeled al-AT from cell culture fluid, cells were subjected to a long pulse interval (1 80 min) and the cell culture fluid harvested and stored at -70°C. Methods for solubilization of cells and clarification of cell lysates after labeling have been described (30) . Total protein synthesis was estimated bv trichloroacetic acid precipitation of aliquots of cell lysates and culture fluid (3 1).
Zmmunoprecipitation and analytical gel electrophoresis. Aliquots of cell lysate or medium were incubated overnight at 4°C in 1% Triton X-100/1.0% SDS/O.5% deoxycholic acid, with excess antibody. Immune complexes were precipitated with excess formalin-fixed staphylococci-bearing protein A, washed, released by boiling in sample buffer, and applied to 9.0% SDS-PAGE under reducing conditions (32) . I4C-methylated molecular size markers (200 000, 92 500, 68 000, 46 000, 30 000, and 17 000 mol wt) were incubated on all gels. After electrophoresis, gels were stained in Coomassie brilliant blue, destained, impregnated with 2,5-diphenyloxazole (EN3HANCE; New England Nuclear), and dried for fluorography on XAR x-ray film (Eastman Kodak Co., Rochester, NY). SDS-polyacrylamide gels of purified proteins or reaction mixtures were subjected to staining in Coomassie brilliant blue alone and standard unlabeled protein mixtures used as relative molecular size markers. In specific experiments, purified proteins or reaction mixtures were subjected to native gel electrophoresis according to a previously described protocol (33) . Laser densitometer 2222 ultrascan XL from LKB Instruments, Inc., Houston, TX, was used for scanning of fluorograms.
Detection of RNA by RNA blot analysis. Total cellular RNA was isolated from adherent monolayers of monocytes, macrophages, or hepatoma cells by guanidine isothiocyanate extraction and ethanol precipitation (34) . RNA was subjected to agaroseformaldehyde gel electrophoresis and transferred to nitrocellulose filters (35) . Filters were then hybridized with 32P-labeled cDNA specific for human al-AT (17) .
Determination of 125Z-pseudomonas elastase uptake. Pseudomonas elastase was labeled with I2'I using chloramine T and purified by gel filtration on Sephadex GlO. The specific radioactivity of various preparations was -3700 cpm/ng. For uptake studies, separate monolayers of monocytes were washed with PBS and incubated at 37°C for specified time intervals with Iz5I-pseudomonas elastase in Medium 199 containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid and 0.1 mg/ mL cytochrome C. The cells were then rinsed in PBS at 4°C and cell-associated radioactivity determined in 1 N NaOH homogenates. Specific uptake was defined as the difference between total and nonspecific uptake. Nonspecific uptake was determined by the addition of 200-fold molar excess of unlabeled pseudomonas elastase during the uptake experiments.
RESULTS
Pseudomonas elastase cleaves monocyte-derived al-AT. To determine the effect of pseudomonas elastase on monocytederived al-AT, we first examined its effect on purified human plasma al-AT. Reaction mixtures of LYI-AT and pseudomonas elastase or porcine pancreatic elastase were subjected to SDS-PAGE after incubation at 37°C for 60 min (Fig. la) . Pseudomonas elastase cleaves aI-AT in concentration-dependent fashion. The effect is first evident at a pseudomonas elastase concentration of 10 ng/mL in Figure l a but is observed at a concentration of 100 pg/mL in other experiments (data not shown). There is a step-wise cleavage with at least two intermediate cleavage products before reaching the well-characterized -51-kD modified form of a,-AT as a result of the action of pseudomonas elastase at 10 pg/mL. This form of a]-AT comigrated with the 51-kD form of al-AT in the reaction mixture containing al-AT and serine-type pancreatic elastase ( Fig. 1 a, last lane) .
Monocyte-derived al-AT was reacted with pseudomonas elastase and pancreatic elastase in the same concentrations. Separate monolayers of monocytes were labeled with 35S-methionine for 180 min. The resulting cell culture fluid, containing newly synthesized and radiolabeled a]-AT as well as other secretory proteins, was harvested, clarified, and incubated for 60 min at 37°C with pseudomonas elastase or pancreatic elastase. The reaction mixture was then subjected to immunoprecipitation with antihuman al-AT, followed by SDS-PAGE and fluorography (Fig.  lb) . There are several forms of a]-AT in the cell culture fluid of The cleavage is first apparent at pseudomonas elastase concentrations between 0.1 and 1.0 pg/mL. Thus, a much higher concentration of pseudomonas elastase is required to cleave monocyte-derived a,-AT (lowest effective concentration 0.1 -1 .O pg/mL) than to cleave purified plasma al-AT (lowest effective concentration 0.1-1.0 ng/mL). This difference could not be attributed to the salt concentration in the reaction mixture; i.e. there was no difference when the NaCl concentration of the reaction buffer was reduced from 1 10 to 55 mM (data not shown). Furthermore, this difference could not be attributed to the presence of complex as well as native forms of al-AT in monocyte culture fluid as compared to the presence of only the native form of &,-AT in purified plasma a,-AT preparations-there was no difference in the concentration of pseudomonas elastase required to cleave purified plasma al-AT alone as compared to purified plasma al-AT after it had been reacted with purified human neutrophil elastase under conditions that resulted in steady-state concentrations of native and complex form of a,-AT (data not shown). Thus, it is much more likely that the difference in effective concentrations of pseudomonas elastase on al-AT in monocyte culture fluid is related to another constituent of that culture fluid, such as a2-macroglobulin (see below).
Results shown in Figure 1 b also indicate that there is step-wise cleavage with at least two intermediate cleavage products. The final cleavage product comigrates with the modified form of a,-AT as demonstrated in the last lane. In this case, there has been dissociation of the endogenous a,-AT-elastase complex leaving only modified al-AT by generating a vast excess of serine elastase with exogenous pancreatic elastase. The progressive disappearance of the 66-and 75-kD a,-AT-elastase complexes during incubation with increasing concentrations of pseudomonas elastase or pancreatic elastase is also probably attributable to the progressive functional inactivation of a,-AT.
Pseudomonas elastase mediates an increase in net synthesis of &]-AT by monocytes. Separate monolayers of monocytes were incubated for 4 h at 37°C with serum-free control medium, medium supplemented with pseudomonas elastase in a concentration that cleaves monocyte-derived aI-AT (100 ng/mL; Fig.  lb) , or medium supplemented with pancreatic elastase in a concentration previously shown to be effective in mediating upregulation of a,-AT synthesis (50 ng/mL; refs. 18 and 19). Monocytes were then rinsed and subjected to metabolic labeling and newly synthesized, radiolabeled a,-AT in cell lysates was demonstrated by immunoprecipitation, SDS-PAGE followed by fluorography (Fig. 2) . ~seudomonas elastase mediates an increase in svnthesis of al-AT. In this ex~eriment. the effect of ~seudom-onas elastase was compared to the effect of serine-type pancreatic elastase. However, the effect of pancreatic elastase is submaximal, inasmuch as its full effect requires 18-24 h (18, 19) . When compared to pancreatic elastase or neutrophil elastase at optimal conditions, the magnitude of the effect of pseudomonas elastase and the serine elastases is similar (data not shown). The effect is specific in that other proteins, such as complement protein factor B, are not affected in the same experiment (Fig. 2, right panel) . The effect of pseudomonas elastase is also concentration-dependent (Fig. 3) . The lowest effective concentration for mediating the regulatory effect, 100 ng/mL, correlates with the lowest effective concentration for limited proteolysis of monocyte-derived a]-AT. The effect of pseudomonas elastase on synthesis of a,-AT reaches a plateau at 250-500 ng/mL.
The effect of pseudomonas elastase on synthesis of a,-AT is also time-dependent. It is first evident after a 4-h incubation and is maximal after 8 h. The effect wanes by 8-16 h (data not shown).
Pseudomonas elastase also mediates an increase in steady-state levels of a,-AT mRNA (Fig. 4) . Monocytes were incubated for 4 h in serum-free control medium or medium supplemented with We next examined the possibility that the effect of pseudomonas elastase on al-AT synthesis is similar to that of neutrophil elastase in terms of cell-surface recognition and signal transduction (Fig. 5) . In this case, we examined the effect on monocyte a,-AT synthesis of pseudomonas elastase in the absence or presence of antiserum to the receptor binding domain of a,-AT. The antiserum was raised in rabbits by immunization of a keyhole limpet hemocyanin-conjugated synthetic peptide (peptide 105Y) corresponding to the ligand binding domain of a,-AT (20) . It recognizes al-AT-elastase or al-AT-trypsin complexes by ELISA and immunoprecipitation, blocks binding and uptake of al-AT-neutrophil elastase and a]-AT-trypsin complexes, and blocks the effect of neutrophil elastase and a]-AT-neutrophil elastase complexes on synthesis of al-AT in monocytes (Joslin G, Fallon RJ, Perlmutter DH, unpublished observations).
For the experiment shown in Figure 5 , monocytes were incubated for 4 h in control serum-free medium or medium supplemented with pseudomonas elastase in suboptimal concentrations alone or together with several antisera or antibodies. Monocytes were then rinsed and subjected to metabolic labeling and newly synthesized radiolabeled al-AT was detected in the same analytical system as described above. The increase in synthesis mediated by pseudomonas elastase was blocked by antiserum to receptor-binding domain of al-AT but not by preimmune rabbit serum or by an antibody to the receptor-binding domain of a2-macroglobulin. These data suggest that a receptor-binding domain on endogenous al-AT molecules is exposed by the distinct -4-Pseudomonas elastase Fig. 4 . Effect of pseudomonas elastase on steady-state levels of a,-AT mRNA. Monocvtes were incubated for 4 h in serum-free control medium or medium supplemented with pseudomonas elastase at 250 ng/mL. Total cellular RNA was then isolated and subjected to RNA blot analysis as described in Materials and Methods. Equal amounts of RNA were loaded in each lane. There was no difference in the intensity of ethidiumbromide stained ribosomal RNA (data not shown). Twenty-eight3 and 18s ribosomal RNA markers are indicated at the right margin. The results were representative of two separate experiments.
pseudomonas elastase in a concentration of 250 ng/mL. Total cellular RNA was then isolated, purified, and subjected to RNA blot analysis. There is a significant increase in a]-AT mRNA levels in the presence of pseudomonas elastase. The magnitude of the effect is similar to that of neutrophil elastase (1 8, 19) . 5 . Antibody to the receptor-binding domain of a,-AT blocks the effect of pseudomonas elastase on synthesis of a,-AT. Monocytes were incubated for 4 h at 37°C in serum-free control medium, medium supplemented with pseudomonas elastase in suboptimal concentrations (100 ng/mL), medium supplemented with pseudomonas elastase together with a MAb to the receptor-binding domain of a?-macroglobulin (F2B2, 0.6 pg/mL final concentration), rabbit antiserum to the receptor binding domain of a,-AT (rabbit anti-keyhole limpet hemocyanin conjugated peptide 105Y, 1.2 lg/mL final concentration, or preimmune rabbit serum (1.2 pg/mL final concentration). Synthesis of a,-AT was examined as described above and results are shown as fold increase over control on the basis of densitometric scanning of fluorograms. The mean rtr 1 SD from three separate experiments is shown. Antibody, antiserum, or serum used in this experiment had no independent effect on synthesis of a,-AT (data not shown).
enzymatic action of exogenous pseudomonas elastase and is recognized by the SEC receptor to mediate up-regulation of al-AT gene expression.
Uptake of pseudomonas elastase by monocytes. To determine the fate of pseudomonas elastase, we incubated monocytes with radioiodinated pseudomonas elastase at 37°C for time intervals up to 4 h. Duplicate monolayers were incubated with IL2'-pseudomonas elastase in the presence of 200-fold molar excess of unlabeled pseudomonas elastase. Cell monolayers were then rinsed vigorously and cell-associated radioactivity measured (Fig.  6a) . The results indicate that there is specific, time-dependent uptake of pseudomonas elastase. There is a relatively rapid increase in cell-associated radioactivity. Rate of accumulation within the cells decreases by 30-60 min (Fig. 6a) and reaches a  plateau by 8-16 h (data not shown) .
We next examined the possibility that uptake of '251-pseudomonas elastase in these experiments represents uptake of pseudomonas elastase-a2-macroglobulin complexes. Human monocytes synthesize and secrete a2-macroglobulin (37) . Monocytes also express a2-macroglobulin-proteinase receptors that are capable of uptake and endocytosis of a2-macroglobulin-pseudomonas elastase complexes (15) . Monocytes were incubated with Iz5I-pseudomonas elastase at 37°C for 1 h in the absence or presence of 100-fold molar excess unlabeled pseudomonas elastase, antibody to the receptor-binding domain of or2-macroglobulin (kindly provided by Dr. F. van Leuven, Leuven, Belgium and described in ref. 38) , or antiserum to the receptor-binding domain of &,-AT as described above (Fig. 6b) . After 2 h, the cells were washed and lysed and cell-associated radioactivity determined. The results indicate that uptake of pseudomonas elastase is blocked by antibody to the receptor-binding domain of a2-macroglobulin but not by antibody to the ligand-binding domain of al-AT. Uptake of pseudomonas elastase is therefore mediated, at least in part, by the a2-macroglobulin-proteinase receptor.
To further establish that uptake of pseudomonas elastase by monocytes represents uptake of pseudomonas elastase-a2-macroglobulin complexes, we examined the possibility that pseudomonas elastase binds to and induces the conformational change of a2-macroglobulin to the "fast" form, which is recognized by the a2-macroglobulin-proteinase receptor (38, 39) . First, we demonstrated that pseudomonas elastase mediated a concentrationdependent conversion of purified human plasma a2-macroglobulin to its "fast" conformation in native PAGE (Fig. 7a) . Second, we demonstrated that 1251-pseudomonas elastase associated with unlabeled a2-macroglobulin by autoradiography of the same native polyacrylamide gel (Fig. 7a) . Third, we showed that the interaction between unlabeled pseudomonas elastase and a2-macroglobulin resulted in similar cleavage products as that between unlabeled trypsin and a2-macroglobulin as shown by SDS-PAGE (Fig. 7b) . Finally, we showed that 1251-pseudomonas elastase was associated with endogenous a2-macroglobulin after incubation with monocytes at 37°C for 4 h (Fig. 8) . For this experiment, cell culture fluid was harvested and cells lysed after the incubation and the resulting samples subjected to immunoprecipitation with antibody to a2-macroglobulin followed by SDS-PAGE under reducing conditions and finally autoradiography (Fig. 6, left panel) . The results indicate the presence of an -32-kD radiolabeled polypeptide corresponding to pseudomonas elastase and -90-and -120-kD radiolabeled polypeptides.
The 90-kD polypeptide corresponds to the monomeric form of oc2-macroglobulin-pseudomonas elastase complexes. The 120-kD polypeptide corresponds to heat-induced fragmentation of the internal thiolester of a2-macroglobulin dimers in complex with pseudomonas elastase (as shown in similar studies with bacterial and neutrophil proteinases in refs. 33 and 40). Radiolabeled -32-kD, -90-kD, and -120-kD polypeptides are also immunoprecipitated from cell lysates by anti-a2-macroglobulin (data not shown). Moreover, using these samples, a radiolabeled polypeptide corresponding to "fast" a2-macroglobulin is demonstrated in autoradiography of native PAGE (data not shown). The formation of a complex with a2-macroglobulin is specific as shown by immunoprecipitation of an aliquot of the same cell culture fluid with antibody to al-AT (Fig. 8, right panel) . In this case, there is only an -32-kD polypeptide corresponding to the radiolabeled pseudomonas elastase used as ligand in the experiment. These results suggest that 1251-pseudomonas elastase binds to endogenous monocyte a2-macroglobulin and that uptake of elastase is mediated by the a2-macroglobulin-proteinase receptor. These results also suggest that the higher concentrations of pseudomonas elastase necessary for cleavage of al-AT in monocyte culture fluid as compared with purified plasma al-AT are, at least in part, due to binding of that elastase by endogenous a 2 -macroglobulin and uptake of the resulting complex by a2-macroglobulin-proteinase receptor-mediated endocytosis.
DISCUSSION
The results of these experiments suggest that mononuclear phagocytes, cells that are widely distributed and even reside ,$ $' Fig. 6 . Uptake of pseudomonas elastase by monocytes. A, monocytes were incubated at 37°C with 1251-pseudomonas elastase (500 ng/mL) in the absence (total binding) or presence (nonspecific binding) of 200-fold molar excess unlabeled pseudomonas elastase for the specified time intervals. Cells were then rinsed in PBS and lysed in 1 N NaOH and cell-associated radioactivity was measured. Specific binding represents the difference between total and nonspecific binding. B, monocytes were incubated at 37°C with 1251-pseudomonas elastase (500 ng/mL) in the absence or presence of unlabeled pseudomonas elastase (100 pg/mL), antiserum to the receptor-binding domain of a,-AT (1.2 pg/mL), or antibody to the receptor binding domain of a*-macroglobulin (0.6 pg/mL). Cell associated radioactivity was measured and results expressed as percent inhibition of uptake. within epithelial linings, are endowed with a complex repertoire of responses for controlling proteolytic activity at sites of tissue injury. Mononuclear phagocytes secrete a number of protease inhibitors including al-AT and az-macroglobulin. We show here that mononuclear phagocytes possess a signal transduction pathway for increasing the synthesis of al-AT when extracellular a,-AT is cleaved and inactivated by the action of a prototype metalloenzyme, pseudomonas elastase. It was of some interest to us that higher concentrations of pseudomonas elastase were necessary to cleave al-AT in the culture fluid of monocytes as compared with purified plasma al-AT. This does not necessarily mean that the a,-AT molecule in monocyte culture fluid is structurally or functionally different than that present in plasma. We reasoned that it was much more likely that another product of the monocyte was involved and showed that the difference in concentrations of pseudomonas elastase necessary for cleavage of al-AT in monocyte culture fluid as compared with purified plasma a,-AT could be in part related to binding of pseudomonas elastase to monocyte-derived a2-macroglobulin. We also showed that the mononuclear phagocytes possess the capacity for receptor-mediated uptake and degradation of endogenous a2-macroglobulin-exogenous pseudomonas elastase complexes.
The mechanism by which neutrophil elastase-al-AT and proteolytic inactivated al-AT regulate mononuclear phagocyte a,-AT gene expression has been the subject of detailed investigation (1 [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . We have recently shown that a region within the carboxy terminal fragment of al-AT is recognized by an abundant highafinity receptor, SEC receptor, on the plasma membrane of human hepatoma-derived hepatocytes and human mononuclear phagocytes (20) . This receptor-binding domain is not exposed in native al-AT, but becomes available for cell-surface binding when a,-AT undergoes structural rearrangement during complex formation or during proteolytic inactivation. Because the specificity of this ligand receptor interaction is similar to the specificity of in vivo al-AT-proteinase complex clearance (41) , and because there is endocytosis and lysosomal degradation of a,-AT-protease complexes mediated by the SEC receptor in vitro (42) , it is likely that the SEC receptor is responsible for clearance of a,-ATelastase complexes as well as for activating the signal transduction pathway for increasing al-AT gene expression.
Several results in our report indicate that a similar mechanism is responsible for the regulatory effect of pseudomonas elastase on al-AT gene expression-i.e. that pseudomonas elastase induces structural rearrangement of endogenous &,-AT during proteolytic inactivation, thereby exposing a domain for recognition by the SEC receptor. First, there is a strong correlation between the concentrations necessary for proteolytic inactivation of al-AT and those necessary for increasing synthesis of &,-AT. Second, there is a correlation between the time frame within which pseudomonas elastase affects al-AT synthesis and the time frame for uptake and removal of pseudomonas elastase from its putative substrate. Third, a pretranslational mechanism is re-sponsible for the effect of pseudomonas elastase on al-AT gene expression as well as for signals transduced by the SEC receptor (1 [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Finally, the regulatory effect of pseudomonas elastase on al-AT synthesis is specifically blocked by antibody to the domain of al-AT that is recognized by the SEC receptor.
Further studies will be necessary to more completely understand the interaction between pseudomonas elastase or other metalloproteinases and endogenous a2-macroglobulin. a2-Macroglobulin does not completely inactivate its proteinase ligands. In fact, some enzymes have enhanced activity when bound to a2-macroglobulin (43). Nevertheless, the net physiologic activity of enzymes bound to a2-macroglobulin is probably negligible, inasmuch as there is rapid receptor-mediated clearance and intracellular degradation of a2-macroglobulin-protease complexes in many cell types including mononuclear phagocytes, fibroblasts, syncytiotrophoblasts, and hepatocytes (1 5). We show here that pseudomonas elastase binds to endogenous a2-macroglobulin and that there is specific, time-dependent uptake of pseudomonas elastase by cultured monocytes. Finally, uptake of pseudomonas elastase is blocked by antibody to the receptorbinding domain of a2-macroglobulin.
Other physiologic factors are likely to have an impact on proteolytic activity at sites of tissue injury and on the ability of the host to respond to destructive metallo-enzymes of bacterial or endogenous origin. First, other exogenous and endogenous proteinases may cleave al-AT in the same region. A metalloproteinase secreted by mouse macrophages (9, lo), a human neutrophil-derived metalloenzyme (1 1, 14) , and thiol-protease cathepsin L (12) are examples. Second, reactive oxygen intermediates may also have the same net effect as pseudomonas elastase. Oxidation of the reactive site Met358 of al-AT renders the inhibitor susceptible to cleavage at the Met358-Ser359 bond by serine proteinase without complex formation (4, 6, 8) . Third, a secondary influx of neutrophils into the site of injury may be anticipated, especially because elastase-al-AT complexes and proteolytically inactivated al-AT possess potent chemoattractant properties (44, 45). Fourth, other endogenous inhibitors, produced locally by mononuclear phagocytes and fibroblasts and diffusing from the blood stream into peripheral tissues, may dramatically affect proteolytic activity during the host response to inflammation and tissue injury.
